nach oben

Erschienen in:

29.07.2015 | Case Report

Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation

verfasst von: Yuki Kakefuda, Akira Sato, Hiroaki Watabe, Hideaki Aihara, Hidetaka Nishina, Yuichi Noguchi, Tomoya Hoshi, Kazutaka Aonuma

Erschienen in: Heart and Vessels | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Very late stent thrombosis (VLST) is a serious complication after percutaneous coronary intervention. However, the best therapy for VLST with late-acquired incomplete stent apposition and incomplete neointimal coverage remains unknown. In these cases, neointimal coverage was nearly complete and no late-acquired malapposition was detected at 18 months after Endeavor zotarolimus-eluting stent (ZES) implantation for the treatment of VLST with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation. We presented that Endeavor ZES implantation may become an attractive therapeutic strategy for the treatment of VLST with late-acquired incomplete stent apposition and incomplete neointimal coverage.

Nur mit Berechtigung zugänglich

Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356:998–1008CrossRefPubMed

Yamawaki M, Onuma Y, Nakano M, Muramatsu T, Nakatani S, Ishibashi Y, Ishimori H, Hirano K, Ito Y, Tsukahara R, Muramatsu T (2014) Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound. Heart Vessels. doi:10.1007/s00380-014-0545-0

Mahmoud KD, Vlaar PJ, van den Heuvel AF, Hillege HL, Zijlstra F, de Smet BJ (2011) Usefulness of thrombus aspiration for the treatment of coronary stent thrombosis. Am J Cardiol 108:1721–1727CrossRefPubMed

Nasuno T, Tokura M, Kageyama M, Toyoda S, Sakuma M, Komatsu T, Taguchi I, Abe S, Inoue T (2015) The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term. Heart Vessels. doi:10.1007/s00380-015-0676-y PubMedCentral

Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE, Investigators ENDEAVORII (2006) Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 114:798–806CrossRefPubMed

Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, Choi EY, Lee SH, Ko YG, Choi D, Hong MK, Jang Y (2009) Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implamtation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv 2:1240–1247CrossRefPubMed

Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C (2009) Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. Euro Interv 5:157–165

von Birgelen C, Basalus MW (2010) On the loss of the phosphorylcholine-based DES coating on the abluminal surface of Endeavor stents. Catheter Cardiovasc Interv 76:158–159CrossRef

Titel: Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation
verfasst von: Yuki Kakefuda
Akira Sato
Hiroaki Watabe
Hideaki Aihara
Hidetaka Nishina
Yuichi Noguchi
Tomoya Hoshi
Kazutaka Aonuma
Publikationsdatum: 29.07.2015
Verlag: Springer Japan
Erschienen in: Heart and Vessels / Ausgabe 7/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-015-0720-y

Neu im Fachgebiet Kardiologie

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Efficacy of Endeavor zotarolimus-eluting stent implantation for the treatment of very late stent thrombosis with late-acquired incomplete stent apposition after sirolimus-eluting stent implantation

Abstract

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2016

Does reducing ischemia time justify to catheterize firstly the culprit artery in every primary PCI?

Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients

Extracellular matrix remodeling in wound healing of critical size defects in the mitral valve leaflet

Axillary artery cannulation provides balanced cerebral oxygenation

Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients

Linkage of sleep-disordered breathing and acute aortic dissection with patent false lumen

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie